WO2008106659A3 - Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith - Google Patents
Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith Download PDFInfo
- Publication number
- WO2008106659A3 WO2008106659A3 PCT/US2008/055562 US2008055562W WO2008106659A3 WO 2008106659 A3 WO2008106659 A3 WO 2008106659A3 US 2008055562 W US2008055562 W US 2008055562W WO 2008106659 A3 WO2008106659 A3 WO 2008106659A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- memory
- cognitive impairment
- associated therewith
- impairment associated
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Abstract
The present invention is a method of treating or preventing mixed and/or manic episodes associated with bipolar I disorder or memory and/or cognitive impairment associated therewith in a patient in need thereof by administering an effective amount of at least one calcium channel modulator selected from (1 ) amlodipine, bepridil, clevidipine, felodipine, isradipine, lacidipine, lercanidipine, manidipine, niguldipine, nilvadipine, nisoldipine, or nitrendipine, or (2) the R-enantiomer of a 1,4-dihydropyridine compound, other than (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)- l,4- dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89245507P | 2007-03-01 | 2007-03-01 | |
US60/892,455 | 2007-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008106659A2 WO2008106659A2 (en) | 2008-09-04 |
WO2008106659A3 true WO2008106659A3 (en) | 2008-10-16 |
Family
ID=39721861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/055562 WO2008106659A2 (en) | 2007-03-01 | 2008-02-29 | Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008106659A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7820691B2 (en) | 2006-08-28 | 2010-10-26 | Medipropharma, Inc. | Indoloquinoline compounds as calcium channel blockers |
WO2014052849A1 (en) * | 2012-09-28 | 2014-04-03 | Elan Pharmaceuticals, Inc. | Combination treatments for bipolar disorders |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567271A (en) * | 1977-06-20 | 1986-01-28 | Sandoz Ltd. | Benzoxadiazoles and benzothiadiazoles |
US6458808B1 (en) * | 2000-12-20 | 2002-10-01 | Osmotica Corp. | Pharmaceutical composition for the treatment of cognitive cerebrovascular disease |
-
2008
- 2008-02-29 WO PCT/US2008/055562 patent/WO2008106659A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567271A (en) * | 1977-06-20 | 1986-01-28 | Sandoz Ltd. | Benzoxadiazoles and benzothiadiazoles |
US6458808B1 (en) * | 2000-12-20 | 2002-10-01 | Osmotica Corp. | Pharmaceutical composition for the treatment of cognitive cerebrovascular disease |
Non-Patent Citations (2)
Title |
---|
SINGH ET AL.: "Renewed Interest in Calcium Channel as Antimania Agents in the Third Millenium", HONG KONG JOURNAL OF PSYCHIATRY, vol. 14, no. 2, 2004, pages 12 - 15 * |
SKOLNICK: "New Pharmacological Strategies", 1997, HUMANA PRESS, TOTOWA, NEW JERSEY, ISBN: 0806034690, article PUCILOWSKI ET AL.: "Calcium Channel Antagonists in Mood Disorders, in Antidepressants", pages: 81 - 102 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US8889190B2 (en) | 2013-03-13 | 2014-11-18 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
US9555005B2 (en) | 2013-03-15 | 2017-01-31 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
Also Published As
Publication number | Publication date |
---|---|
WO2008106659A2 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE399026T1 (en) | COMPOSITIONS CONTAINING L-TYPE CALCIUM CANAL BLOCKERS AND CHOLINESTERASE INHIBITORS | |
WO2008106659A3 (en) | Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith | |
WO2007022924A3 (en) | Pharmaceutical compositions with melting point depressant agents and method of making same | |
WO2003099346A3 (en) | Compositions and methods for coating medical implants | |
WO2005011582A3 (en) | Compositions, methods, devices, and kits for maintaining or enhancing tooth whitening | |
WO2008005427A3 (en) | Pdgf-biomatrix compositions and methods for treating rotator cuff injuries | |
WO2007092755A3 (en) | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 | |
WO2007150075A3 (en) | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | |
EP1974722A3 (en) | Modified dosage forms of tacrolimus | |
DE60143197D1 (en) | CRYSTALLINE FORM OF 5-CHLORO-3- (4-METHANESULFONYLPHENYL) -6'-METHYL-Ä2,3'Ü BIPYRIDINYL AND METHOD OF MANUFACTURING THEREOF | |
IL166795A (en) | N - aryl piperidine substituted biphenylcarboxamides, pharmaceutical composiitons comprising them and method for their preparation | |
SG113556A1 (en) | Graft copolymers, method of making and compositions containing the same | |
WO2000004862A3 (en) | Bioenhanced formulations comprising eprosartan in oral solid dosage form | |
WO2004069215A3 (en) | Dental whitening compositions and methods | |
WO2005000194A3 (en) | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same | |
ATE521611T1 (en) | 1,4-DIHYDROPYRIDINE CONDENSED HETEROCYCLES, PRODUCTION METHOD, USE AND COMPOSITIONS THEREOF | |
WO2006085208A3 (en) | Stable solid dosage forms of amlodipine and benazepril | |
WO2008123582A1 (en) | Tetrahydroisoquinoline compound | |
WO2019008516A3 (en) | Treatment of cancer with dihydropyridines | |
HUP0100844A2 (en) | Method of increasing the biovaliability and tissue penetration of azithromycin | |
AU2003229835A1 (en) | Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier | |
WO2006015970A3 (en) | Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic | |
PE20060946A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING LERCANIDIPINE | |
PE20011163A1 (en) | TREATMENT OF KIDNEY DISORDERS | |
DE60210893D1 (en) | Bolt, thread rolling jaw and method of manufacture of the bolt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08731173 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08731173 Country of ref document: EP Kind code of ref document: A2 |